Iguratimod
Drug timelines are a Plus or Pro feature.
20 regulatory and trial events tracked for Iguratimod, covering 2014-10-23 to 2025-07-10. Get the full timeline:
Most recent: Clinical Trial Update: Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP [Phase 2]